Karen Firestone

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Joshua B. Cohen, as Attorney in Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Karen Firestone:

Company Role Class Num Shares Value Price $ Report Date Ownership
Amylyx Pharmaceuticals, Inc. Director Common Stock 63,100 $785,595 $12.45 23 Dec 2025 Direct
Amylyx Pharmaceuticals, Inc. Director Stock Option (right to buy) 25,000 05 Jun 2025 Direct

Insider Reports Filed by Karen Firestone

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AMLX Amylyx Pharmaceuticals, Inc. 23 Dec 2025 1 +$100,845 4 Director 23 Dec 2025, 20:48
AMLX Amylyx Pharmaceuticals, Inc. 05 Jun 2025 1 $0 4 Director 09 Jun 2025, 16:08
AMLX Amylyx Pharmaceuticals, Inc. 05 Sep 2024 1 +$106,590 4 Director 09 Sep 2024, 16:05
AMLX Amylyx Pharmaceuticals, Inc. 06 Jun 2024 1 $0 4 Director 07 Jun 2024, 16:50
AMLX Amylyx Pharmaceuticals, Inc. 15 Dec 2023 1 +$59,880 4 Director 19 Dec 2023, 16:37
AMLX Amylyx Pharmaceuticals, Inc. 08 Jun 2023 1 $0 4 Director 12 Jun 2023, 19:50
AMLX Amylyx Pharmaceuticals, Inc. 16 Mar 2023 2 +$31,990 4 Director 20 Mar 2023, 20:22
AMLX Amylyx Pharmaceuticals, Inc. 16 Mar 2023 0 $0 3 Director 20 Mar 2023, 20:09